Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -153,494 | -127,130 | -93,783 | -43,843 | -126,874 |
| Depreciation Amortization | -1,568 | -1,568 | -1,488 | -702 | -2,562 |
| Accounts receivable | -12,780 | 599 | 653 | 664 | -4,859 |
| Other Working Capital | -27,914 | -10,850 | 2,654 | -2,586 | 4,933 |
| Other Operating Activity | 33,312 | 14,830 | 10,115 | 4,443 | 32,596 |
| Operating Cash Flow | $-162,444 | $-124,119 | $-81,849 | $-42,024 | $-96,766 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 61,847 | 34,113 | 2,628 | -25,919 | -20,318 |
| PPE Investments | -289 | -272 | -185 | -44 | -295 |
| Investing Cash Flow | $61,558 | $33,841 | $2,443 | $-25,963 | $-20,613 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 24,488 |
| Common Stock Issued | 41,773 | 7,973 | 3 | 34 | 170,131 |
| Other Financing Activity | -1,855 | 629 | 327 | 0 | 0 |
| Financing Cash Flow | $39,918 | $8,602 | $330 | $34 | $194,619 |
| Beginning Cash Position | 173,063 | 173,062 | 173,062 | 173,062 | 95,823 |
| End Cash Position | 112,095 | 91,386 | 93,986 | 105,109 | 173,063 |
| Net Cash Flow | $-60,968 | $-81,676 | $-79,076 | $-67,953 | $77,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -162,444 | -124,119 | -81,849 | -42,024 | -96,766 |
| Capital Expenditure | -289 | -272 | -185 | -44 | -295 |
| Free Cash Flow | -162,733 | -124,391 | -82,034 | -42,068 | -97,061 |